Thanassoulis G - Search Results

1

Cost-effectiveness of Low-density Lipoprotein Cholesterol Level-Guided Statin Treatment in Patients With Borderline Cardiovascular Risk.

Kohli-Lynch CN, Bellows BK, Thanassoulis G, Zhang Y, Pletcher MJ, Vittinghoff E, Pencina MJ, Kazi D, Sniderman AD, Moran AE. Kohli-Lynch CN, et al. Among authors: thanassoulis g. JAMA Cardiol. 2019 Oct 1;4(10):969-977. doi: 10.1001/jamacardio.2019.2851. JAMA Cardiol. 2019. PMID: 31461121 Free PMC article.

2

The causal exposure model of vascular disease.

Sniderman AD, Lawler PR, Williams K, Thanassoulis G, de Graaf J, Furberg CD. Sniderman AD, et al. Among authors: thanassoulis g. Clin Sci (Lond). 2012 Apr;122(8):369-73. doi: 10.1042/CS20110449. Clin Sci (Lond). 2012. PMID: 22187965 Free PMC article.

3

A genetic risk score is associated with incident cardiovascular disease and coronary artery calcium: the Framingham Heart Study.

Thanassoulis G, Peloso GM, Pencina MJ, Hoffmann U, Fox CS, Cupples LA, Levy D, D'Agostino RB, Hwang SJ, O'Donnell CJ. Thanassoulis G, et al. Circ Cardiovasc Genet. 2012 Feb 1;5(1):113-21. doi: 10.1161/CIRCGENETICS.111.961342. Epub 2012 Jan 10. Circ Cardiovasc Genet. 2012. PMID: 22235037 Free PMC article.

4

Comparison of coronary calcium screening versus broad statin therapy for patients at intermediate cardiovascular risk.

Sniderman AD, Thanassoulis G, Lawler PR, Williams K, Furberg CD. Sniderman AD, et al. Among authors: thanassoulis g. Am J Cardiol. 2012 Aug 15;110(4):530-3. doi: 10.1016/j.amjcard.2012.04.025. Epub 2012 May 10. Am J Cardiol. 2012. PMID: 22579082

5

Is lower and lower better and better? A re-evaluation of the evidence from the Cholesterol Treatment Trialists' Collaboration meta-analysis for low-density lipoprotein lowering.

Sniderman A, Thanassoulis G, Couture P, Williams K, Alam A, Furberg CD. Sniderman A, et al. Among authors: thanassoulis g. J Clin Lipidol. 2012 Jul-Aug;6(4):303-9. doi: 10.1016/j.jacl.2012.05.004. Epub 2012 May 30. J Clin Lipidol. 2012. PMID: 22836065

6

Among statin-treated patients, LDL, non-HDL and apoB cholesterol biomarkers were associated with increased risks of cardiovascular events.

Sniderman AD, Thanassoulis G. Sniderman AD, et al. Among authors: thanassoulis g. Evid Based Med. 2013 Apr;18(2):73-4. doi: 10.1136/eb-2012-100787. Epub 2012 Aug 14. Evid Based Med. 2013. PMID: 22893654 No abstract available.

7

Do statins lower testosterone and does it matter?

Sniderman AD, Thanassoulis G. Sniderman AD, et al. Among authors: thanassoulis g. BMC Med. 2013 Feb 28;11:58. doi: 10.1186/1741-7015-11-58. BMC Med. 2013. PMID: 23448188 Free PMC article.

8

Counterpoint: statins do reduce fatal events.

Sniderman AD, Thanassoulis G, Couture P, Williams K, Alam A, Furberg CD. Sniderman AD, et al. Among authors: thanassoulis g. J Clin Lipidol. 2013 May-Jun;7(3):225-7; discussion 228. doi: 10.1016/j.jacl.2012.12.004. Epub 2013 Feb 8. J Clin Lipidol. 2013. PMID: 23725923 No abstract available.

9

Relations of change in plasma levels of LDL-C, non-HDL-C and apoB with risk reduction from statin therapy: a meta-analysis of randomized trials.

Thanassoulis G, Williams K, Ye K, Brook R, Couture P, Lawler PR, de Graaf J, Furberg CD, Sniderman A. Thanassoulis G, et al. J Am Heart Assoc. 2014 Apr 14;3(2):e000759. doi: 10.1161/JAHA.113.000759. J Am Heart Assoc. 2014. PMID: 24732920 Free PMC article.

10

Taking a longer term view of cardiovascular risk: the causal exposure paradigm.

Sniderman AD, Toth PP, Thanassoulis G, Pencina MJ, Furberg CD. Sniderman AD, et al. Among authors: thanassoulis g. BMJ. 2014 May 21;348:g3047. doi: 10.1136/bmj.g3047. BMJ. 2014. PMID: 24850828 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184 results

Search Page

Filters